Lupin Limited, founded in 1968, is a leading global pharmaceutical company based in India, specialising in the development, manufacturing, and marketing of a diverse range of generic and branded medications. Operating primarily in the healthcare sector, Lupin focuses on therapeutic areas such as cardiovascular, diabetes, central nervous system, and anti-infectives, offering products that meet high-quality standards and affordability. The company’s robust pipeline includes oral and injectable formulations, biosimilars, and over-the-counter products, catering to both consumers and healthcare professionals. With a strong international presence across over 100 countries, Lupin is committed to delivering innovative solutions that enhance patient care and improve health outcomes.